Cargando…
COVID-19 vaccines surveillance in France: a global response to a major national challenge
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Société française d'anesthésie et de réanimation (Sfar). Published by Elsevier Masson SAS.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061787/ https://www.ncbi.nlm.nih.gov/pubmed/33895471 http://dx.doi.org/10.1016/j.accpm.2021.100866 |
_version_ | 1783681635494920192 |
---|---|
author | Benkebil, Mehdi Gautier, Sophie Gras-Champel, Valérie Massy, Nathalie Micallef, Joelle Valnet Rabier, Marie-Blanche |
author_facet | Benkebil, Mehdi Gautier, Sophie Gras-Champel, Valérie Massy, Nathalie Micallef, Joelle Valnet Rabier, Marie-Blanche |
author_sort | Benkebil, Mehdi |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8061787 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Société française d'anesthésie et de réanimation (Sfar). Published by Elsevier Masson SAS. |
record_format | MEDLINE/PubMed |
spelling | pubmed-80617872021-04-23 COVID-19 vaccines surveillance in France: a global response to a major national challenge Benkebil, Mehdi Gautier, Sophie Gras-Champel, Valérie Massy, Nathalie Micallef, Joelle Valnet Rabier, Marie-Blanche Anaesth Crit Care Pain Med Editorial Société française d'anesthésie et de réanimation (Sfar). Published by Elsevier Masson SAS. 2021-06 2021-04-22 /pmc/articles/PMC8061787/ /pubmed/33895471 http://dx.doi.org/10.1016/j.accpm.2021.100866 Text en © 2021 Société française d'anesthésie et de réanimation (Sfar). Published by Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Editorial Benkebil, Mehdi Gautier, Sophie Gras-Champel, Valérie Massy, Nathalie Micallef, Joelle Valnet Rabier, Marie-Blanche COVID-19 vaccines surveillance in France: a global response to a major national challenge |
title | COVID-19 vaccines surveillance in France: a global response to a major national challenge |
title_full | COVID-19 vaccines surveillance in France: a global response to a major national challenge |
title_fullStr | COVID-19 vaccines surveillance in France: a global response to a major national challenge |
title_full_unstemmed | COVID-19 vaccines surveillance in France: a global response to a major national challenge |
title_short | COVID-19 vaccines surveillance in France: a global response to a major national challenge |
title_sort | covid-19 vaccines surveillance in france: a global response to a major national challenge |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061787/ https://www.ncbi.nlm.nih.gov/pubmed/33895471 http://dx.doi.org/10.1016/j.accpm.2021.100866 |
work_keys_str_mv | AT benkebilmehdi covid19vaccinessurveillanceinfranceaglobalresponsetoamajornationalchallenge AT gautiersophie covid19vaccinessurveillanceinfranceaglobalresponsetoamajornationalchallenge AT graschampelvalerie covid19vaccinessurveillanceinfranceaglobalresponsetoamajornationalchallenge AT massynathalie covid19vaccinessurveillanceinfranceaglobalresponsetoamajornationalchallenge AT micallefjoelle covid19vaccinessurveillanceinfranceaglobalresponsetoamajornationalchallenge AT valnetrabiermarieblanche covid19vaccinessurveillanceinfranceaglobalresponsetoamajornationalchallenge |